Loading
Latest filing published 19 Oct 2022 for Pasithea Therapeutics Corp., €1,127.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David Delaney has a single filing on record, published on 19 October 2022: an open-market purchase of €1,127 in Pasithea Therapeutics Corp. One trade is not enough to describe a pattern. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration